A randomized placebo-controlled study evaluating the effects of daytime and evening administration of low doses of LSD on cognitive performance, sleep quality, mood, neuroplasticity markers, emotion regulation, quality of life, and immune system response
Latest Information Update: 01 Dec 2021
At a glance
- Drugs Lysergide (Primary)
- Indications Anxiety disorders
- Focus Therapeutic Use
- 16 Nov 2021 Status changed from planning to recruiting, according to a Mindmed media release.
- 22 Jan 2021 New trial record
- 12 Jan 2021 According to a Mindmed media release, company is integrating innovative digital tracking devices and software into the study to better assess LSD's effects on various digital clinical markers on the human body.